Trial intelligence / Profile preview

Prolotherapy versus eccentric loading exercises for painful Achilles tendinosis

ACTRN12607000276459Phase 3Not yet recruiting

Sponsor
Griffith University
Start
Jun 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01

Overview

Phase 3, randomised, open-label trial of dextrose, lidocaine and ropivacaine in chronic Achilles tendinopathy (2 arms), sponsored by Griffith University. Primary endpoint: Victorian Institute of Sport Assessment - Achilles (VISA-A) questionnaire at 12 months. Planned start Jun 2007; status: not yet recruiting.

02

Drugs

dextroselidocaineropivacaine
03

Conditions

chronic Achilles tendinopathy

Beyond the preview

Go deeper on ACTRN12607000276459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000276459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call